Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Winnipeg Lab

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Mar 15, 2021 8:58pm

203 Views

Post# 32804857

RE:RE:RE:RE:RE:Winnipeg Lab

Thank you ScienceFirst, I was under the opinion the company (TLT) would be concentrating their efforts on this Ph2 NMIBC and PH1 Brain & Lung before funding a Coronavirus vaccine since there is sufficient remedies out there all in my opinion. I would guess once TLT does go into vaccine trial it might treat the entire family of Coronavirus instead of just one strain or perhaps I don't fully understand the power of TLD-1433 enough to grasp what it can or can not do. My concern here is they tackle the destruction of Cancer and I would prefer if they found some other company to partnership with and let them fund the trials but again all in my uneducated opinion.

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security